Pfizer Acquires Immuno-Inflammatory Company Arena for US$6.7 B

By Lucy Haggerty

Pharma Deals Review: Vol 2021 Issue 12 (Table of Contents)

Published: 24 Dec-2021

DOI: 10.3833/pdr.v2021.i12.2651     ISSN: 1756-7874

Section: Mergers & Acquisitions



Pfizer has agreed to acquire Arena Pharmaceuticals, a clinical stage company focused on the development of therapies for immuno-inflammatory diseases...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details